Session » Systemic Lupus Erythematosus - Human Etiology and Pathogenesis Poster II
-
Abstract Number: 1845
HMGB1 Early Marker in Lupus Nephritis
-
Abstract Number: 1846
IGFBP-2 As a Novel Biomarker for Disease Activity and Renal Pathology in Lupus Nephritis
-
Abstract Number: 1847
Serum Ferritin and Insulin-like Growth Factor-Binding Protein 2 As Biomarkers of Clinical and Histopathological Treatment Response in Lupus Nephritis
-
Abstract Number: 1848
Increased Expression of Bruton Tyrosine Kinase in Patients with Lupus Nephritis and Its Clinic Significance
-
Abstract Number: 1849
Serum Axl and Tumor Necrosis Factor Receptor II Portend Long-Term Renal Outcome in Lupus Nephritis
-
Abstract Number: 1850
Increased Levels of Immunoglobulin Binding Protein 1 Are Associated with Disease Activity Including Renal Damage in Patients with Systemic Lupus Erythematosus
-
Abstract Number: 1851
Antibody Against Ribonuclease-H Is a Novel Autoantibody Specifically Recognized in Systemic Lupus Erhythematosus
-
Abstract Number: 1852
Association of Antibodies to the NR1 Subunit of N-Methyl-D-Aspartate Receptors with Neuropsychiatric Systemic Lupus Erythematosus
-
Abstract Number: 1853
Binding of a Novel IgG3 VH4-34 Monoclonal Antibody to ssRNA in SLE
-
Abstract Number: 1855
Systemic Lupus Erythematosus Exosomes Contain Distinct RNA Transcripts That Differentiate Disease Activity and Modulate Cellular Function
-
Abstract Number: 1856
Exosomes from Patients with Active Systemic Lupus Erythematosus Induce a Strong Inflammatory Response
-
Abstract Number: 1857
Identification of the Long Noncoding RNA NEAT1 As a Novel Inflammatory Regulator Acting through MAPK Pathway in Human Lupus
-
Abstract Number: 1858
Serum Tartrate Resistant Acid Phosphatase (TRAP) Levels Are Decreased and Associated with Anti-Maa Antibodies in Systemic Lupus Erythematosus (SLE) Patients
-
Abstract Number: 1859
Anti-Interferon Autoantibodies in Systemic Lupus Erythematosus Are Biologically Active and Have Distinct Functions
-
Abstract Number: 1861
Anti-Ds-DNA Antibodies Regulate Atherothrombosis in Systemic Lupus Erythematosus through the Induction of Netosis and the Prothrombotic and Proinflammatory Activities of Monocytes
-
Abstract Number: 1862
Identification of Homogeneous Systemic Lupus Erythematosus (SLE) Patient Groups Using Clustered Autoantibody Reactivities
-
Abstract Number: 1863
Epigenetic Changes in SLE Implicate Enhancers As a Force in Pathologic Cell Behavior
-
Abstract Number: 1864
H3K4me3 Peak Shape Dictates Transcription and Regulates Differential Expression in SLE
-
Abstract Number: 1865
Association Between Changes in Expression of Gene Signatures and Disease Activity Among Patients with Systemic Lupus Erythematosus
-
Abstract Number: 1866
Fall in Dicer1 Gene Expression Flags Abnormal Lymphocyte Activation in Lupus
-
Abstract Number: 1867
Functional Androgen Receptor Variants Associated with Greater Damage in Systemic Lupus Erythematosus
-
Abstract Number: 1868
BLK Pathway-Associated rs13277113 GA Genotype Is More Frequent in Systemic Lupus Erythematosus Patients and Associated with Low Gene Expression and Increased Flares
-
Abstract Number: 1869
Association of CLEC16A with SLE in a Large Multi-Ancestry Cohort and Implication in B-Cell Receptor Signaling